https://www.selleckchem.com/
The 17% and 28% of subjects showed a CMT 250 microns at 3 and 12 months, respectively. The median change in CMT thickness was of -370 and -373.5 microns at 3 and 12 months post-injection respectively ( -value is 0.025). Changes in median IOP at 3 and 12 months post-injection were not statistically significant ( -value is 0.21. Ocular hypertension (OHT) was detected in two eyes (11%). The FAc micro implant has proved efficacy in improving and/or maintaining BVCA in 77% of patients with cDME up to 12 months post-injection. Ocular hypertension is the mos
Curtir
Comentario
Compartilhar
